Skip to main content

LACOSAMIDE ASTRON, LACOSIMPAT, LACOSAMIDE AMEDA, LACOSAMIDE INTAS, LACOSAM (Accord Healthcare Pty Ltd)

Product name
LACOSAMIDE ASTRON, LACOSIMPAT, LACOSAMIDE AMEDA, LACOSAMIDE INTAS, LACOSAM
Date registered
Evaluation commenced
Decision date
Approval time
190 working days (255)
Active ingredients
lacosamide
Registration type
New generic medicine
Indication

LACOSAMIDE ASTRON, LACOSIMPAT, LACOSAMIDE AMEDA, LACOSAMIDE INTAS, LACOSAM (film-coated tablets) are indicated as:

  • monotherapy in the treatment of partial seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older.
  • add-on therapy in the treatment of partial seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older.

Help us improve the Therapeutic Goods Administration site